Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: TSHA) | Delayed: 4.01 -0.11 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.12 | 52 Week High | $ | |||
| Open | $4.07 | 52 Week Low | $ | |||
| Day High | $4.18 | P/E | N/A | |||
| Day Low | $3.94 | EPS | $ | |||
| Volume | 3,105,121 | |||||
